Can Cancer Ever Become a Managed Disease? − How AI-driven Cancer Research in Hungary Can Help Make It Happen

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/ce/32/70/ce327050-b26d-b1f1-85de-7c5722a54a08/mza_15805004325985742129.jpg/600x600bb.jpg

Invest In Hungary

Invest In Hungary by HIPA

11 episodes

6 days ago

A podcast by the Hungarian Investment Promotion Agency (HIPA) on why investing and reinvesting in Hungary is the real deal, featuring leading investors, senior decision makers and seasoned experts that share insights on FDI trends, best practices and market outlook. Hosted by Levente Hörömpöli-Tóth, senior communications expert, HIPA. Theme song: AlexGrohl - Fashion Hip Hop Rock (Stylish Boy), Pixabay

Investing

Business

RSS

All content for Invest In Hungary is the property of Invest In Hungary by HIPA and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Investing

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/38163682/38163682-1704895365124-e1121f78d9bd9.jpg

Can Cancer Ever Become a Managed Disease? − How AI-driven Cancer Research in Hungary Can Help Make It Happen

Invest In Hungary

26 minutes 20 seconds

1 year ago

Can Cancer Ever Become a Managed Disease? − How AI-driven Cancer Research in Hungary Can Help Make It Happen

Many people don’t know the birthplace of digital pathology is Budapest, and a thriving local ecosystem has now paved the way for a new Pathology Innovation Incubator that is meant to take AI-driven cancer diagnostics to the next level. We asked the CEOs of the two global leaders that teamed up for the effort, Mr. Steven Lynum of Epredia and Dr. Béla Molnár of 3DHistech, to talk about the potential this endeavor holds, the role the Hungarian operation can play in the process, and most of all, whether cancer could become a chronic disease that can be managed like diabetes.

Our guests also reflected on

- the chances that waiting times in Hungary could be cut because these efforts take place in Hungary

- what challenges scientists face when using AI to support cancer diagnostics

- staying competitive with emerging companies

- what might be possible if infinite funds were available for cancer research

Read the summary of, and find more links to, the podcast at https://hipa.hu/podcast/, and don’t forget to follow and rate it. Any comments? Send us a message to komm@hipa.hu.

Check out our brand-new editorial content, HIPA Stories – Behind the Ribbon Cutting that showcases exciting tales of the local investor community in the form of in-depth reports. All articles are available at https://hipa.hu/report/.